Filaggrin gene mutations and risk of basal cell carcinoma

British Journal of Dermatology

Volumn 169, Issue 5, 2013, Pages 1162-1164

  Kaae, J ^a   Thyssen, J P ^a   Johansen, J D ^a   Meldgaard, M ^a   Linneberg, A ^b   Allen, M ^c   Skov, L ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FILAGGRIN; IMMUNOSUPPRESSIVE AGENT; VITAMIN D;

ADULT; AGED; ATOPIC DERMATITIS; BASAL CELL CARCINOMA; BLOOD SAMPLING; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DENMARK; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CASE-CONTROL STUDIES; HOMOZYGOTE; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MIDDLE AGED; MUTATION; RISK FACTORS; SKIN NEOPLASMS;

EID: 84887099661     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12573     Document Type: Letter

References (10)

1. Nan H, Xu M, Kraft P, et al,. Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma. Hum Mol Genet 2011; 20: 3718-24.
2. Jensen AO, Svaerke C, Körmendiné Farkas D, et al,. Atopic dermatitis and risk of skin cancer: a Danish nationwide cohort study (1977-2006). Am J Clin Dermatol 2012; 13: 29-36.
3. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al,. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-6.
4. Mildner M, Jin J, Eckhart L, et al,. Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model. J Invest Dermatol 2010; 130: 2286-94.
5. Barresi C, Stremnitzer C, Mlitz V, et al,. Increased sensitivity of histidinemic mice to UVB radiation suggests a crucial role of endogenous urocanic acid in photoprotection. J Invest Dermatol 2011; 131: 188-94.
6. Thyssen JP, Thuesen B, Huth C, et al,. Skin barrier abnormality caused by filaggrin (FLG) mutations is associated with increased serum 25-hydroxyvitamin D concentrations. J Allergy Clin Immunol 2012; 130: 1204-7.
7. Skov L, Allen MH, Bang B, et al,. Basal cell carcinoma is associated with high TNF-α release but not with TNF-α polymorphism at position 308. Exp Dermatol 2003; 12: 772-6.
8. Thyssen JP, Carlsen BC, Menné T, et al,. Filaggrin null mutations increase the risk and persistence of hand eczema in subjects with atopic dermatitis: results from a general population study. Br J Dermatol 2010; 163: 115-20.
9. Meldgaard M, Szecsi PB, Carlsen BC, et al,. A novel multiplex analysis of filaggrin polymorphisms: a universally applicable method for genotyping. Clin Chim Acta 2012; 413: 1488-92.
10. Elias PM, Williams ML,. Comment on 'Does a history of eczema predict a future basal cell carcinoma?' J Invest Dermatol 2013; 133: 1676-7.